晚期非小细胞肺癌中的MET变化
Gabriel Cavalcante Lima Chagas1, Amanda Ribeiro Rangel1, Badi El Osta2
1Post-Graduation Program in Medical Sciences, Department of Internal Medicine, Faculty of Medicine, Federal University of Ceará, Costa Mendes, 1608. 4(o) andar. Rodolfo Teófilo, Fortaleza, CE 60430-140, Brazil.
Current problems in cancer
|March 13, 2024
概括
精准医学的进步准了特定的癌症驱动因素,改善了晚期癌症的结果. 对于MET改变的肺癌,新的向疗法提供了对不良预后的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 精准医学识别瘤分子异常,用于向治疗.
- 向治疗可以提高癌症的疗效,并降低具有特定瘤原因驱动因素的晚期癌症的毒性.
- 转移性肺癌中的分子瘤测序识别了前期向治疗改善结果的驱动因素.
研究的目的:
- 审查MET变化的非小细胞肺癌 (NSCLC) 的作用.
- 讨论目前和新兴的针对MET驱动NSCLC的向治疗方法.
- 突出结合疗法在克服耐药性的潜力.
主要方法:
- 在瘤学中精准医学的文献综述.
- 对NSCLC中MET变化的数据进行分析.
- 关于MET变化的FDA批准和正在研究的治疗方法的摘要.
主要成果:
- 在高达60%的NSCLC中发生MET变化,并且与预后不佳有关.
- 卡普马提尼布和特波提尼布已获得FDA批准,用于MET外显子14跳转突变.
- 目前正在开发研究药物,包括与EGFR抑制剂结合使用以对抗耐药性.
结论:
- 向疗法已经改变了先进的癌症治疗.
- 在NSCLC中,MET变化是一个重大挑战,但新的药物具有前景.
- 组合策略可以克服耐药性并改善MET改变的肺癌患者的治疗结果.
关键词:
在MET中放大放大功率.在MET外形14跳转突变中,MET突变14跳转突变.在MET中,过度表达过度.非小细胞肺癌 (NSCLC) 是一种非小细胞肺癌.精确瘤学是一门精确的专业.有针对性的治疗.c-MET变更的情况.更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.4K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K